Why BGPT?
logo

Check Claims Before You Publish

See how your reported results read as versioned evidence records β€” linked to experiments and limitations.Know what the science actually supports before you trust the answer.

Press Enter ↡ to review claims


     Quick Explanation



    Nicolas Thierry-Mieg is an established computational/systems biologist (h-index ~30–34, ~5,000 citations, 80–96 works) who has co-authored landmark interactome papers () and a coherent male-infertility gene-discovery program, though much output is collaborative middle-authorship rather than independent first-author contributions.


     Long Explanation



    Track Record and Citation Metrics

    OpenAlex records ~96 works with ~5,471 citations and h-index 34 (Semantic Scholar data: 80 papers, h-index 30, 4,833 citations); the metrics are consistent across databases. His peak-cited works are methodologically formative in interactomics and systems biology: the 2000 Science two-hybrid interaction map (763 citations) , the 2012 Nature proto-genes/de novo gene birth paper (673 citations) , and the 2013 AJHG DNAH1 male-infertility paper (480 citations) . OpenAlex per-year counts show sustained productivity with a 2018 peak (~988 citations that year) and a shift from C. elegans/pooling/interactome methods (2000–2012) to a focused human male-infertility genetics program (2013–present).

    The BFWalk Paper (2026) as Rigor Evidence

    His 2026 BFWalk preprint illustrates applied methodological strength: a non-backtracking, in-degree-normalized propagation algorithm benchmarked on a 17,638-protein human interactome against RWR and NetCore using leave-one-out cross-validation with Wilcoxon signed-rank tests. BFWalk significantly outperformed both comparators for MMAF (AUC 0.659 vs 0.468 and 0.565, p < 10⁻⁴) and dyschromatopsia (0.660 vs 0.573 and 0.593), with no significant differences for cardiomyopathy or kidney disease, and Spearman ρ ~0.70–0.72 linking its advantage to low/intermediate-degree genes β€” an honest, quantitative anti-hub-bias analysis . Strengths: transparent statistics, pre-specified comparators, released code and validation scripts, declared no competing interests, and openly reported null/intermediate results. Limitations: computational-only validation, four phenotypes on one interactome, and AUC as a coarse global metric β€” claims stop at benchmark evidence.

    Critical Assessment

    The portfolio reveals a genuine systems-biology-to-human-genetics arc with several highly cited, independently verifiable discoveries. Blindspots: the dominant pattern is middle/last-adjacent authorship on consortium papers, so first-author intellectual ownership of the flagship works cannot be established from supplied data; his institution field is blank in OpenAlex (CNRS affiliation appears only via co-author records); and the BFWalk benchmark lacks experimental confirmation of novel candidates, a standard limitation for network-propagation methods. Overall: a scientifically credible, statistically careful researcher with strong methodological breadth (two-hybrid pooling design, interactome databases like MatrixDB, prion biology, clinical genomics) rather than a single-theme specialist. Confidence: moderate β€” based on three supplied sources, not an independent citation audit.



    Feedback:    

    Updated: October 09, 2026

     BGPT Author Review



    Scientific Quality

    70%

    Sustained contributions across interactomics (C. elegans two-hybrid maps, smart-pooling design), systems biology (proto-genes), and a coherent male-infertility gene-discovery program with multiple AJHG/Nature Communications papers and high citation counts. BFWalk shows competent benchmark design and honest statistical reporting. Limitations: unclear independent leadership on flagship papers (mostly middle authorship), no supplied evidence of experimental validation in the computational work, and metrics may reflect co-authorship leverage in consortium-era biology.



    Communication Quality

    60%

    Papers are method-clear with reproducible code release, but titles and outputs are dense and technique-heavy; communication is solidly academic, not notably accessible or pedagogical. Open-access availability on several key works helps dissemination.



    Author Novelty

    70%

    Co-authored genuinely field-shaping ideas: shifted transversal design smart-pooling, proto-genes/de novo gene birth framework, and a 2026 algorithmic advance (non-backtracking walks with in-degree normalization) addressing hub bias. The male-infertility gene discoveries are new but follow an established exome-discovery template; BFWalk novelty is incremental over existing propagation methods.



    Scientific Rigor

    80%

    BFWalk uses pre-specified comparators, nonparametric significance testing, effect sizes with AUCs, correlation analyses, external tissue-expression validation (GTEx), declared no competing interests, and public code/analysis scripts β€” high benchmark hygiene. Deductions: computational-only validation, coarse AUC metric acknowledged by authors, arbitrary hub cutoff, and four phenotypes on a single interactome limit generalization.

     Hypothesis Graveyard



    BFWalk superiority is general across phenotypes β€” weakened by the paper's own null results for hypertrophic cardiomyopathy and chronic kidney disease.


    The 2026 work being a first-author-led extension of the author's interactome expertise β€” the supplied OpenAlex data shows most flagship works are middle-author contributions, so attribution of intellectual leadership is uncertain.

     Science Art


    Author Review: Nicolas Thierry-Mieg Science Art

     Science Movie



    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT